Inventor · disambiguated record
Yasuki Kamai
Also filed as: KAMAI YASUKI
6 granted patents·4 pending applications·18 citations·filing 2013–2025
77Inventor score
Files withDAIICHI SANKYO CO LTD10
Top patents by PatentIndex Score
10 records- 0185US9481733B2Anti-FGFR2 antibodies and pharmaceutical compositions thereofDAIICHI SANKYO CO LTD·Filed 2015·Granted Nov 1, 2016·6 cites·43 claims
- 0284US11273155B2Combination of antibody-drug conjugate and immune checkpoint inhibitorDAIICHI SANKYO CO LTD·Filed 2017·Granted Mar 15, 2022·3 cites·25 claims
- 0381US9714298B2Anti-FGFR2 antibodies and methods of use thereof for treating cancerDAIICHI SANKYO CO LTD·Filed 2013·Granted Jul 25, 2017·6 cites·46 claims
- 0471US9931401B2Combination comprising anti-fibroblast growth factor receptor 2 (FGFR2) antibody and a tyrosine kinase inhibitorDAIICHI SANKYO CO LTD·Filed 2014·Granted Apr 3, 2018·3 cites·49 claims
- 0570US12319736B2Combination of antibody-drug conjugate and immune checkpoint inhibitorDAIICHI SANKYO CO LTD·Filed 2022·Granted Jun 3, 2025·0 cites·31 claims
- 0668US2025340644A1Combination of antibody-drug conjugate and immune checkpoint inhibitorDAIICHI SANKYO CO LTD·Filed 2025·Application pending·0 cites
- 0761US2025276079A1COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH EZH1 and/or EZH2 INHIBITORDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 0853US2023293714A1Combination of anti-her2 antibody-drug conjugate with her dimerization inhibitorDAIICHI SANKYO CO LTD·Filed 2021·Application pending·0 cites
- 0951US2022040324A1Combination of antibody-drug conjugate and kinase inhibitorDAIICHI SANKYO CO LTD·Filed 2019·Application pending·0 cites
- 1049US12497465B2Combination of antibody-drug conjugate and tubulin inhibitorDAIICHI SANKYO CO LTD·Filed 2019·Granted Dec 16, 2025·0 cites·47 claims
Join the waitlist — get patent alerts
Get an alert when Yasuki Kamai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →